No Data
No Data
Dare Bioscience Regains Nasdaq Compliance
Dare Bioscience (DARE) said Friday that it has regained compliance with Nasdaq's minimum bid price requirements.The biopharmaceutical company said its closing bid price remained at least $1 per
Express News | Daré Bioscience Regains Compliance With Nasdaq Minimum Bid Price Rule
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Dare Bioscience To Carry Out 1-for-12 Reverse Stock Split On July 1st, 2024
June 27th (Eastern Time) - $Dare Bioscience(DARE.US)$ is about to implement a 1-for-12 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from July 1st, 2024.$Dare
Express News | Dare Bioscience Shares Are Trading Lower After the Company Announced a 1-for-12 Reverse Stock Split
No Data